ES2940071T3 - Componentes y procedimientos de amplificación isotérmica - Google Patents
Componentes y procedimientos de amplificación isotérmica Download PDFInfo
- Publication number
- ES2940071T3 ES2940071T3 ES20182776T ES20182776T ES2940071T3 ES 2940071 T3 ES2940071 T3 ES 2940071T3 ES 20182776 T ES20182776 T ES 20182776T ES 20182776 T ES20182776 T ES 20182776T ES 2940071 T3 ES2940071 T3 ES 2940071T3
- Authority
- ES
- Spain
- Prior art keywords
- nucleic acid
- sequence
- primer
- amplification
- cases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 136
- 238000011901 isothermal amplification Methods 0.000 title claims abstract description 39
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 387
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 357
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 357
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 317
- 230000003321 amplification Effects 0.000 claims abstract description 311
- 230000000295 complement effect Effects 0.000 claims abstract description 115
- 230000000694 effects Effects 0.000 claims abstract description 70
- 102000004190 Enzymes Human genes 0.000 claims abstract description 66
- 108090000790 Enzymes Proteins 0.000 claims abstract description 66
- 125000006850 spacer group Chemical group 0.000 claims abstract description 44
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 33
- 230000002441 reversible effect Effects 0.000 claims abstract description 30
- 239000000047 product Substances 0.000 claims description 138
- 238000006243 chemical reaction Methods 0.000 claims description 113
- 108020004414 DNA Proteins 0.000 claims description 102
- 108091034117 Oligonucleotide Proteins 0.000 claims description 73
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 59
- 238000001514 detection method Methods 0.000 claims description 59
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 29
- 108060002716 Exonuclease Proteins 0.000 claims description 27
- 102000013165 exonuclease Human genes 0.000 claims description 27
- 239000012634 fragment Substances 0.000 claims description 23
- 102000053602 DNA Human genes 0.000 claims description 17
- 239000002679 microRNA Substances 0.000 claims description 10
- 239000013612 plasmid Substances 0.000 claims description 10
- 108020004999 messenger RNA Proteins 0.000 claims description 8
- 108700011259 MicroRNAs Proteins 0.000 claims description 7
- 238000010839 reverse transcription Methods 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 230000003612 virological effect Effects 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 230000002438 mitochondrial effect Effects 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 108020004513 Bacterial RNA Proteins 0.000 claims description 3
- 108020000999 Viral RNA Proteins 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 108091092328 cellular RNA Proteins 0.000 claims description 3
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 2
- 101710116602 DNA-Binding protein G5P Proteins 0.000 claims description 2
- 101710162453 Replication factor A Proteins 0.000 claims description 2
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 claims description 2
- 101710176276 SSB protein Proteins 0.000 claims description 2
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims description 2
- 102100034343 Integrase Human genes 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 241000206602 Eukaryota Species 0.000 claims 1
- 238000013519 translation Methods 0.000 abstract description 4
- 239000013615 primer Substances 0.000 description 228
- 125000003729 nucleotide group Chemical group 0.000 description 135
- 239000002773 nucleotide Substances 0.000 description 124
- 239000000523 sample Substances 0.000 description 102
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 53
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 53
- 239000003795 chemical substances by application Substances 0.000 description 43
- 102000040430 polynucleotide Human genes 0.000 description 42
- 108091033319 polynucleotide Proteins 0.000 description 42
- 239000002157 polynucleotide Substances 0.000 description 42
- 150000001413 amino acids Chemical group 0.000 description 33
- 230000004048 modification Effects 0.000 description 31
- 238000012986 modification Methods 0.000 description 31
- 102100031780 Endonuclease Human genes 0.000 description 27
- 230000008569 process Effects 0.000 description 25
- 108060004795 Methyltransferase Proteins 0.000 description 23
- 230000002255 enzymatic effect Effects 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- 239000000872 buffer Substances 0.000 description 20
- 238000003556 assay Methods 0.000 description 17
- 239000000203 mixture Substances 0.000 description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 16
- 238000003776 cleavage reaction Methods 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 230000007017 scission Effects 0.000 description 16
- 238000012163 sequencing technique Methods 0.000 description 16
- 241000498849 Chlamydiales Species 0.000 description 15
- 230000027455 binding Effects 0.000 description 14
- 239000000975 dye Substances 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 108010091086 Recombinases Proteins 0.000 description 13
- 102000018120 Recombinases Human genes 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 108090000944 RNA Helicases Proteins 0.000 description 11
- 102000004409 RNA Helicases Human genes 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- -1 cDNA Proteins 0.000 description 11
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000004925 denaturation Methods 0.000 description 10
- 230000036425 denaturation Effects 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 10
- 239000002105 nanoparticle Substances 0.000 description 10
- 238000011897 real-time detection Methods 0.000 description 10
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 10
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 108091008146 restriction endonucleases Proteins 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 8
- 229960002685 biotin Drugs 0.000 description 8
- 235000020958 biotin Nutrition 0.000 description 8
- 239000011616 biotin Substances 0.000 description 8
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000003607 modifier Substances 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 108090000364 Ligases Proteins 0.000 description 7
- 102000003960 Ligases Human genes 0.000 description 7
- 238000002875 fluorescence polarization Methods 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 108010068698 spleen exonuclease Proteins 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 101710183280 Topoisomerase Proteins 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 230000000692 anti-sense effect Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000003599 detergent Substances 0.000 description 6
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 238000011002 quantification Methods 0.000 description 6
- 241000606153 Chlamydia trachomatis Species 0.000 description 5
- 108010010677 Phosphodiesterase I Proteins 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 230000006037 cell lysis Effects 0.000 description 5
- 230000009089 cytolysis Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 238000009830 intercalation Methods 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000002987 primer (paints) Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 108090000133 DNA helicases Proteins 0.000 description 4
- 102000003844 DNA helicases Human genes 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 108010042407 Endonucleases Proteins 0.000 description 4
- 108091093037 Peptide nucleic acid Proteins 0.000 description 4
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000001818 capillary gel electrophoresis Methods 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 102100038351 ATP-dependent DNA helicase Q5 Human genes 0.000 description 3
- 101710132587 ATP-dependent DNA helicase Q5 Proteins 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 3
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 108020004459 Small interfering RNA Proteins 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000001687 destabilization Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 3
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 230000005291 magnetic effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 102000044158 nucleic acid binding protein Human genes 0.000 description 3
- 108700020942 nucleic acid binding protein Proteins 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000012175 pyrosequencing Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000011178 triphosphate Nutrition 0.000 description 3
- 239000001226 triphosphate Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 108020001019 DNA Primers Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 102100033711 DNA replication licensing factor MCM7 Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 2
- 102100029075 Exonuclease 1 Human genes 0.000 description 2
- 102100034553 Fanconi anemia group J protein Human genes 0.000 description 2
- 101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 108091092878 Microsatellite Proteins 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108091081548 Palindromic sequence Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 241000589596 Thermus Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000000368 destabilizing effect Effects 0.000 description 2
- 238000007847 digital PCR Methods 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 108010086271 exodeoxyribonuclease II Proteins 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000007614 genetic variation Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000007855 methylation-specific PCR Methods 0.000 description 2
- 108091070501 miRNA Proteins 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- OZNBTMLHSVZFLR-GWTDSMLYSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one;6-amino-1h-pyrimidin-2-one Chemical compound NC=1C=CNC(=O)N=1.C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OZNBTMLHSVZFLR-GWTDSMLYSA-N 0.000 description 1
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- 102100029325 ATP-dependent DNA helicase PIF1 Human genes 0.000 description 1
- 102100030088 ATP-dependent RNA helicase A Human genes 0.000 description 1
- 101710164022 ATP-dependent RNA helicase A Proteins 0.000 description 1
- 102100024738 ATP-dependent RNA helicase DDX19A Human genes 0.000 description 1
- 102100038263 ATP-dependent RNA helicase DDX55 Human genes 0.000 description 1
- 208000035657 Abasia Diseases 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 101001125884 Autographa californica nuclear polyhedrosis virus Per os infectivity factor 1 Proteins 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 102100035631 Bloom syndrome protein Human genes 0.000 description 1
- 108091009167 Bloom syndrome protein Proteins 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102100031265 Chromodomain-helicase-DNA-binding protein 2 Human genes 0.000 description 1
- 102100038215 Chromodomain-helicase-DNA-binding protein 7 Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 108010051219 Cre recombinase Proteins 0.000 description 1
- 229930183912 Cytidylic acid Natural products 0.000 description 1
- 108010060424 DEAD Box Protein 20 Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102100038826 DNA helicase MCM8 Human genes 0.000 description 1
- 102100038830 DNA helicase MCM9 Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 102100039606 DNA replication licensing factor MCM3 Human genes 0.000 description 1
- 102100034001 DNA replication licensing factor MCM5 Human genes 0.000 description 1
- 102100033720 DNA replication licensing factor MCM6 Human genes 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 101100048967 Enterobacteria phage T4 uvsY gene Proteins 0.000 description 1
- 101800001466 Envelope glycoprotein E1 Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108010046276 FLP recombinase Proteins 0.000 description 1
- 101710093590 Fanconi anemia group J protein Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100031885 General transcription and DNA repair factor IIH helicase subunit XPB Human genes 0.000 description 1
- 102100035184 General transcription and DNA repair factor IIH helicase subunit XPD Human genes 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
- 102100029977 Helicase SKI2W Human genes 0.000 description 1
- 101710143454 Helicase SKI2W Proteins 0.000 description 1
- 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010056307 Hin recombinase Proteins 0.000 description 1
- 101000722210 Homo sapiens ATP-dependent DNA helicase DDX11 Proteins 0.000 description 1
- 101001125842 Homo sapiens ATP-dependent DNA helicase PIF1 Proteins 0.000 description 1
- 101000901942 Homo sapiens ATP-dependent DNA/RNA helicase DHX36 Proteins 0.000 description 1
- 101001041697 Homo sapiens ATP-dependent RNA helicase DDX1 Proteins 0.000 description 1
- 101001041703 Homo sapiens ATP-dependent RNA helicase DDX18 Proteins 0.000 description 1
- 101000830459 Homo sapiens ATP-dependent RNA helicase DDX19A Proteins 0.000 description 1
- 101000830477 Homo sapiens ATP-dependent RNA helicase DDX19B Proteins 0.000 description 1
- 101000912684 Homo sapiens ATP-dependent RNA helicase DDX24 Proteins 0.000 description 1
- 101000912706 Homo sapiens ATP-dependent RNA helicase DDX25 Proteins 0.000 description 1
- 101000923749 Homo sapiens ATP-dependent RNA helicase DDX39A Proteins 0.000 description 1
- 101000870662 Homo sapiens ATP-dependent RNA helicase DDX3X Proteins 0.000 description 1
- 101000870664 Homo sapiens ATP-dependent RNA helicase DDX3Y Proteins 0.000 description 1
- 101000874173 Homo sapiens ATP-dependent RNA helicase DDX42 Proteins 0.000 description 1
- 101000830424 Homo sapiens ATP-dependent RNA helicase DDX50 Proteins 0.000 description 1
- 101000883797 Homo sapiens ATP-dependent RNA helicase DDX51 Proteins 0.000 description 1
- 101000883804 Homo sapiens ATP-dependent RNA helicase DDX54 Proteins 0.000 description 1
- 101000883820 Homo sapiens ATP-dependent RNA helicase DDX55 Proteins 0.000 description 1
- 101000907886 Homo sapiens ATP-dependent RNA helicase DHX15 Proteins 0.000 description 1
- 101000907919 Homo sapiens ATP-dependent RNA helicase DHX29 Proteins 0.000 description 1
- 101000901948 Homo sapiens ATP-dependent RNA helicase DHX30 Proteins 0.000 description 1
- 101000901934 Homo sapiens ATP-dependent RNA helicase DHX33 Proteins 0.000 description 1
- 101000864666 Homo sapiens ATP-dependent RNA helicase DHX8 Proteins 0.000 description 1
- 101000696694 Homo sapiens ATP-dependent RNA helicase SUPV3L1, mitochondrial Proteins 0.000 description 1
- 101000952099 Homo sapiens Antiviral innate immune response receptor RIG-I Proteins 0.000 description 1
- 101000777079 Homo sapiens Chromodomain-helicase-DNA-binding protein 2 Proteins 0.000 description 1
- 101000883739 Homo sapiens Chromodomain-helicase-DNA-binding protein 7 Proteins 0.000 description 1
- 101000957174 Homo sapiens DNA helicase MCM8 Proteins 0.000 description 1
- 101000957164 Homo sapiens DNA helicase MCM9 Proteins 0.000 description 1
- 101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 description 1
- 101000963174 Homo sapiens DNA replication licensing factor MCM3 Proteins 0.000 description 1
- 101001017545 Homo sapiens DNA replication licensing factor MCM5 Proteins 0.000 description 1
- 101001018484 Homo sapiens DNA replication licensing factor MCM6 Proteins 0.000 description 1
- 101000880945 Homo sapiens Down syndrome cell adhesion molecule Proteins 0.000 description 1
- 101000848171 Homo sapiens Fanconi anemia group J protein Proteins 0.000 description 1
- 101000920748 Homo sapiens General transcription and DNA repair factor IIH helicase subunit XPB Proteins 0.000 description 1
- 101000876511 Homo sapiens General transcription and DNA repair factor IIH helicase subunit XPD Proteins 0.000 description 1
- 101000907912 Homo sapiens Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 Proteins 0.000 description 1
- 101000720856 Homo sapiens Probable ATP-dependent RNA helicase DDX10 Proteins 0.000 description 1
- 101001041721 Homo sapiens Probable ATP-dependent RNA helicase DDX17 Proteins 0.000 description 1
- 101000912686 Homo sapiens Probable ATP-dependent RNA helicase DDX23 Proteins 0.000 description 1
- 101000870728 Homo sapiens Probable ATP-dependent RNA helicase DDX27 Proteins 0.000 description 1
- 101000870730 Homo sapiens Probable ATP-dependent RNA helicase DDX28 Proteins 0.000 description 1
- 101000870734 Homo sapiens Probable ATP-dependent RNA helicase DDX31 Proteins 0.000 description 1
- 101000830411 Homo sapiens Probable ATP-dependent RNA helicase DDX4 Proteins 0.000 description 1
- 101000874165 Homo sapiens Probable ATP-dependent RNA helicase DDX41 Proteins 0.000 description 1
- 101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 description 1
- 101000874142 Homo sapiens Probable ATP-dependent RNA helicase DDX46 Proteins 0.000 description 1
- 101000830414 Homo sapiens Probable ATP-dependent RNA helicase DDX47 Proteins 0.000 description 1
- 101000830410 Homo sapiens Probable ATP-dependent RNA helicase DDX49 Proteins 0.000 description 1
- 101000952113 Homo sapiens Probable ATP-dependent RNA helicase DDX5 Proteins 0.000 description 1
- 101000883801 Homo sapiens Probable ATP-dependent RNA helicase DDX52 Proteins 0.000 description 1
- 101000883798 Homo sapiens Probable ATP-dependent RNA helicase DDX53 Proteins 0.000 description 1
- 101000951948 Homo sapiens Probable ATP-dependent RNA helicase DDX56 Proteins 0.000 description 1
- 101000952097 Homo sapiens Probable ATP-dependent RNA helicase DDX59 Proteins 0.000 description 1
- 101000919019 Homo sapiens Probable ATP-dependent RNA helicase DDX6 Proteins 0.000 description 1
- 101000952078 Homo sapiens Probable ATP-dependent RNA helicase DDX60 Proteins 0.000 description 1
- 101000901938 Homo sapiens Probable ATP-dependent RNA helicase DHX34 Proteins 0.000 description 1
- 101000901928 Homo sapiens Probable ATP-dependent RNA helicase DHX35 Proteins 0.000 description 1
- 101000864678 Homo sapiens Probable ATP-dependent RNA helicase DHX37 Proteins 0.000 description 1
- 101000864677 Homo sapiens Probable ATP-dependent RNA helicase DHX40 Proteins 0.000 description 1
- 101000583797 Homo sapiens Protein MCM10 homolog Proteins 0.000 description 1
- 101000722214 Homo sapiens Putative ATP-dependent RNA helicase DDX12 Proteins 0.000 description 1
- 101000864681 Homo sapiens Putative ATP-dependent RNA helicase DHX57 Proteins 0.000 description 1
- 101000901964 Homo sapiens Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 Proteins 0.000 description 1
- 101000639763 Homo sapiens Regulator of telomere elongation helicase 1 Proteins 0.000 description 1
- 101000908580 Homo sapiens Spliceosome RNA helicase DDX39B Proteins 0.000 description 1
- 101000894871 Homo sapiens Transcription regulator protein BACH1 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 241000282842 Lama glama Species 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000203357 Methanococcaceae Species 0.000 description 1
- 241000203353 Methanococcus Species 0.000 description 1
- 108010051862 Methylmalonyl-CoA mutase Proteins 0.000 description 1
- 102100030979 Methylmalonyl-CoA mutase, mitochondrial Human genes 0.000 description 1
- 108091092919 Minisatellite Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101710147059 Nicking endonuclease Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102100026100 Nucleolar RNA helicase 2 Human genes 0.000 description 1
- 101710118021 Nucleolar RNA helicase 2 Proteins 0.000 description 1
- 102100021010 Nucleolin Human genes 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical class C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102100038267 Probable ATP-dependent RNA helicase DDX52 Human genes 0.000 description 1
- 102100022424 Probable ATP-dependent RNA helicase DHX35 Human genes 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102100030962 Protein MCM10 homolog Human genes 0.000 description 1
- 102100025313 Putative ATP-dependent RNA helicase DDX12 Human genes 0.000 description 1
- 102100030092 Putative ATP-dependent RNA helicase DHX57 Human genes 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000205160 Pyrococcus Species 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 108091028733 RNTP Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108010068097 Rad51 Recombinase Proteins 0.000 description 1
- 102000002490 Rad51 Recombinase Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000001218 Rec A Recombinases Human genes 0.000 description 1
- 108010055016 Rec A Recombinases Proteins 0.000 description 1
- 102000019196 RecQ Helicases Human genes 0.000 description 1
- 108010012737 RecQ Helicases Proteins 0.000 description 1
- 102100034469 Regulator of telomere elongation helicase 1 Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 102100027160 RuvB-like 1 Human genes 0.000 description 1
- 101710111834 RuvB-like 1 Proteins 0.000 description 1
- 102100027092 RuvB-like 2 Human genes 0.000 description 1
- 101710111831 RuvB-like 2 Proteins 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 1
- 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 1
- 102100024690 Spliceosome RNA helicase DDX39B Human genes 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000204993 Thermococcaceae Species 0.000 description 1
- 241000205188 Thermococcus Species 0.000 description 1
- 241001092905 Thermophis Species 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
- 108010064672 Tre-Recombinase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
- FOGRQMPFHUHIGU-UHFFFAOYSA-N Uridylic acid Natural products OC1C(OP(O)(O)=O)C(CO)OC1N1C(=O)NC(=O)C=C1 FOGRQMPFHUHIGU-UHFFFAOYSA-N 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- 201000011032 Werner Syndrome Diseases 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 238000003016 alphascreen Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 150000004662 dithiols Chemical class 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000011842 forensic investigation Methods 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000815 hypotonic solution Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 108010044762 nucleolin Proteins 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000003322 phosphorimaging Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 108091007428 primary miRNA Proteins 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000004908 prostatic fluid Anatomy 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000037425 regulation of transcription Effects 0.000 description 1
- 230000009712 regulation of translation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- 239000002342 ribonucleoside Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000001324 spliceosome Anatomy 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000006648 viral gene expression Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/10—Nucleotidyl transfering
- C12Q2521/101—DNA polymerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/10—Nucleotidyl transfering
- C12Q2521/107—RNA dependent DNA polymerase,(i.e. reverse transcriptase)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/113—Time
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2561/00—Nucleic acid detection characterised by assay method
- C12Q2561/113—Real time assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Tires In General (AREA)
- Amplifiers (AREA)
- Signal Processing For Digital Recording And Reproducing (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/090,405 US9617587B1 (en) | 2016-04-04 | 2016-04-04 | Isothermal amplification components and processes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2940071T3 true ES2940071T3 (es) | 2023-05-03 |
Family
ID=58348016
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES20182776T Active ES2940071T3 (es) | 2016-04-04 | 2017-03-06 | Componentes y procedimientos de amplificación isotérmica |
| ES22165594T Active ES2988526T3 (es) | 2016-04-04 | 2017-03-06 | Componentes y procedimientos de amplificación isotérmica |
| ES17711527T Active ES2881509T3 (es) | 2016-04-04 | 2017-03-06 | Componentes y procedimientos de amplificación isotérmica |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES22165594T Active ES2988526T3 (es) | 2016-04-04 | 2017-03-06 | Componentes y procedimientos de amplificación isotérmica |
| ES17711527T Active ES2881509T3 (es) | 2016-04-04 | 2017-03-06 | Componentes y procedimientos de amplificación isotérmica |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9617587B1 (https=) |
| EP (4) | EP3760735B1 (https=) |
| JP (4) | JP6758474B2 (https=) |
| CN (1) | CN109196114A (https=) |
| AU (2) | AU2017247133B2 (https=) |
| CA (1) | CA3018202A1 (https=) |
| ES (3) | ES2940071T3 (https=) |
| WO (1) | WO2017176404A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11299777B2 (en) | 2016-04-04 | 2022-04-12 | Nat Diagnostics, Inc. | Isothermal amplification components and processes |
| US9617587B1 (en) * | 2016-04-04 | 2017-04-11 | Nat Diagnostics, Inc. | Isothermal amplification components and processes |
| KR101884793B1 (ko) * | 2017-11-23 | 2018-08-02 | 강원대학교산학협력단 | Cage 단백질의 생산 및 정제 방법 |
| CN110558279B (zh) * | 2019-09-16 | 2021-11-16 | 南方科技大学 | 一种药物筛选模型、药物筛选方法及其应用 |
| EP4308724A4 (en) * | 2021-03-19 | 2025-05-14 | Becton, Dickinson and Company | ISOTHERMAL AMPLIFICATION OF PATHOGENS |
| WO2023150710A1 (en) | 2022-02-05 | 2023-08-10 | Becton, Dickinson And Company | Non-opaque lytic buffer composition formulations |
| US20250059612A1 (en) | 2022-02-05 | 2025-02-20 | Becton, Dickinson And Company | Method for separating genomic dna for amplification of short nucleic acid targets |
| JP2025507309A (ja) | 2022-02-14 | 2025-03-18 | ベクトン・ディキンソン・アンド・カンパニー | 核酸増幅のための内部対照 |
| CN120019163A (zh) * | 2022-09-07 | 2025-05-16 | 贝克顿迪金森公司 | 古细菌聚合酶扩增 |
| EP4584392A1 (en) | 2022-09-07 | 2025-07-16 | Becton, Dickinson and Company | Hairpin internal control for isothermal nucleic acid amplification |
| JP2025531820A (ja) | 2022-09-07 | 2025-09-25 | ベクトン・ディキンソン・アンド・カンパニー | 検出特異性改善のための修飾分子ビーコン |
| EP4627112A1 (en) | 2022-12-01 | 2025-10-08 | Becton, Dickinson and Company | Asymmetric hairpin probes for nucleic acid detection |
| CN116286720A (zh) * | 2023-03-29 | 2023-06-23 | 赛纳生物科技(北京)有限公司 | 一种dna聚合酶 |
| WO2024216077A1 (en) | 2023-04-13 | 2024-10-17 | Becton, Dickinson And Company | Method for categorizing molecular diagnostic signals in real time |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5693517A (en) | 1987-06-17 | 1997-12-02 | Roche Molecular Systems, Inc. | Reagents and methods for coupled high temperature reverse transcription and polymerase chain reactions |
| US5705345A (en) | 1991-01-10 | 1998-01-06 | Amersham International Plc | Methods and kits for preparing nucleic acids using cyclodextrin |
| US5422241A (en) | 1991-07-03 | 1995-06-06 | Ambion, Inc. | Methods for the recovery of nucleic acids from reaction mixtures |
| AU699232B2 (en) | 1994-03-10 | 1998-11-26 | Gen-Probe Incorporated | Method for suppressing inhibition of enzyme-mediated reactions by ionic detergents |
| US20050089918A1 (en) | 1998-02-23 | 2005-04-28 | Amersham Biosciences Uk Limited | In-situ cell extraction and assay method |
| US6204375B1 (en) | 1998-07-31 | 2001-03-20 | Ambion, Inc. | Methods and reagents for preserving RNA in cell and tissue samples |
| US6777210B1 (en) | 1998-09-24 | 2004-08-17 | Ambion, Inc. | Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1 |
| US8268605B2 (en) * | 1999-10-29 | 2012-09-18 | Agilent Technologies, Inc. | Compositions and methods utilizing DNA polymerases |
| JP4542312B2 (ja) | 2001-03-09 | 2010-09-15 | ニューゲン テクノロジーズ， インコーポレイテッド | Ｒｎａ配列の増幅のための方法および組成物 |
| KR20040007620A (ko) | 2001-06-12 | 2004-01-24 | 다카라 바이오 가부시키가이샤 | 핵산 증폭 또는 검출용 시약의 안정화 방법 및 보존 방법 |
| WO2003008624A2 (en) | 2001-07-15 | 2003-01-30 | Keck Graduate Institute | Nucleic acid amplification using nicking agents |
| DE10147439B4 (de) | 2001-09-26 | 2014-01-30 | Qiagen Gmbh | Verfahren zur Isolierung von DNA aus biologischen Proben |
| US7297485B2 (en) | 2001-10-15 | 2007-11-20 | Qiagen Gmbh | Method for nucleic acid amplification that results in low amplification bias |
| DE60322044D1 (de) | 2002-02-21 | 2008-08-21 | Asm Scient Inc | Rekombinase-polymerase-amplifikation |
| US7638612B2 (en) | 2002-09-03 | 2009-12-29 | Quanta Biosciences, Inc. | Compositions and methods for cDNA synthesis |
| US7662594B2 (en) | 2002-09-20 | 2010-02-16 | New England Biolabs, Inc. | Helicase-dependent amplification of RNA |
| WO2005093065A1 (en) | 2004-03-16 | 2005-10-06 | Roche Diagnostics Gmbh | Improved method of isolating nucleic acids |
| ES2425354T3 (es) | 2004-06-01 | 2013-10-14 | Alere San Diego, Inc. | Amplificación por recombinasa-polimerasa |
| JP5027126B2 (ja) | 2005-07-25 | 2012-09-19 | アリーア サン ディエゴ， インコーポレイテッド | リコンビナーゼポリメラーゼ増幅を多重化するための方法 |
| US8551697B1 (en) | 2005-12-09 | 2013-10-08 | Applied Biosystems, Llc | Electrochemical polynucleotide detection comprising ligation |
| US8071308B2 (en) | 2006-05-04 | 2011-12-06 | Alere San Diego, Inc. | Recombinase polymerase amplification |
| US7858363B2 (en) | 2006-07-22 | 2010-12-28 | Zymo Research Corporation | Plasmid DNA isolation |
| JP4918409B2 (ja) | 2006-07-26 | 2012-04-18 | 西川ゴム工業株式会社 | 核酸配列の増幅方法 |
| EP2108048A1 (en) | 2007-01-17 | 2009-10-14 | Meridian Bioscience, Inc. | Stable reagents and kits useful in loop-mediated isothermal amplification (lamp) |
| EP2140033B1 (en) * | 2007-03-28 | 2012-10-10 | Signal Diagnostics | System and method for high resolution analysis of nucleic acids to detect sequence variations |
| US8008010B1 (en) * | 2007-06-27 | 2011-08-30 | Applied Biosystems, Llc | Chimeric oligonucleotides for ligation-enhanced nucleic acid detection, methods and compositions therefor |
| US9689031B2 (en) | 2007-07-14 | 2017-06-27 | Ionian Technologies, Inc. | Nicking and extension amplification reaction for the exponential amplification of nucleic acids |
| US8435741B2 (en) | 2007-07-26 | 2013-05-07 | Fujifilm Corporation | Isothermal nucleic acid amplification method using surfactant |
| JP2009048280A (ja) | 2007-08-15 | 2009-03-05 | Nikon Corp | 機構解析プログラム |
| CA2695420A1 (en) * | 2007-08-23 | 2009-02-26 | Novartis Ag | Methods for detecting oligonucleotides |
| US20090162856A1 (en) | 2007-11-06 | 2009-06-25 | Hayato Miyoshi | Rna detection method |
| CA2964559C (en) | 2007-11-27 | 2020-01-14 | Bio-Rad Laboratories, Inc. | Reduced inhibition of one-step rt-pcr |
| GB0814570D0 (en) | 2008-08-08 | 2008-09-17 | Diagnostics For The Real World | Isolation of nucleic acid |
| US20110256592A1 (en) | 2008-12-12 | 2011-10-20 | Eurogentec S.A | Use of cyclodextrins to improve the specificity, sensitivity and yield of nucleic acid amplification reactions |
| JP5616584B2 (ja) | 2009-01-09 | 2014-10-29 | 富士フイルム株式会社 | 核酸配列の複製方法 |
| JP5847076B2 (ja) | 2009-05-20 | 2016-01-20 | バイオサイト インコーポレイテッド | Ｄｎａグリコシラーゼ／リアーゼおよびａｐエンドヌクレアーゼ基質 |
| ES3022638T3 (en) | 2009-06-05 | 2025-05-28 | Abbott Diagnostics Scarborough Inc | Recombinase polymerase amplification reagents |
| BR112012006757A2 (pt) | 2009-09-25 | 2015-09-08 | Alere San Diego Inc | detecção de ácidos nucleicos em matrizes brutas |
| EP2534463B1 (en) | 2010-02-11 | 2020-01-08 | ChemoMetec A/S | Method for analysis of cellular dna content |
| EP2418286A1 (en) | 2010-08-10 | 2012-02-15 | QIAGEN GmbH | Improved method for isothermal amplification of nucleic acids |
| TW201239086A (en) | 2011-03-23 | 2012-10-01 | Genereach Biotechnology Corp | Polymerase chain reaction solution |
| BR112013025758B1 (pt) | 2011-04-07 | 2021-04-06 | Abbott Diagnostics Scarborough, Inc. | Monitoramento de misturas de amplificação de recombinase polimerase |
| US9957558B2 (en) | 2011-04-28 | 2018-05-01 | Life Technologies Corporation | Methods and compositions for multiplex PCR |
| WO2012154934A1 (en) | 2011-05-11 | 2012-11-15 | New England Biolabs, Inc. | Dna polymerase variants with reduced exonuclease activity and uses thereof |
| CA2881200A1 (en) | 2012-02-14 | 2013-08-22 | Great Basin Scientific | Methods of isothermal amplification using blocked primers |
| JP5958034B2 (ja) | 2012-04-11 | 2016-07-27 | 富士レビオ株式会社 | 分子ビーコン型プローブを用いた標的核酸の検出方法 |
| WO2013169861A1 (en) | 2012-05-09 | 2013-11-14 | Bio-Rad Laboratories, Inc. | Buffer for one-step dna extraction |
| CN114214394A (zh) | 2012-06-08 | 2022-03-22 | 爱奥尼安技术公司 | 核苷酸扩增反应 |
| PH12012000185A1 (en) | 2012-06-26 | 2014-02-24 | Univ Of The Philippines | Detection of pathogens |
| EP2898069B1 (en) | 2012-09-19 | 2018-04-11 | Beckman Coulter, Inc. | Use of divalent ions, proteases, detergents, and low ph in the extraction of nucleic acids |
| GB201219137D0 (en) | 2012-10-24 | 2012-12-05 | Ge Healthcare Uk Ltd | Direct nucleic acid amplification kit, reagent and method |
| GB201220662D0 (en) | 2012-11-16 | 2013-01-02 | ALERE TECHNOLOGIES GmbH | Assays |
| JP5904153B2 (ja) | 2013-03-29 | 2016-04-13 | ソニー株式会社 | 核酸増幅反応用試料の調製方法、核酸増幅方法、固相状核酸増幅反応用試薬及びマイクロチップ |
| US10443094B2 (en) | 2014-03-26 | 2019-10-15 | General Electric Company | Solid phase isothermal amplification |
| EP3233128A4 (en) | 2014-12-18 | 2018-05-23 | GE Healthcare UK Limited | Analyte detection on a solid support by nucleic acid amplification coupled to an immunoassay |
| US9868944B2 (en) | 2014-12-19 | 2018-01-16 | Roche Molecular Systems, Inc. | Reaction mixtures |
| US10822645B1 (en) | 2014-12-23 | 2020-11-03 | Global Life Sciences Solutions Operations UK Ltd | Methods and reagents for reverse-transcription polymerase chain reaction |
| US10072309B1 (en) | 2015-05-08 | 2018-09-11 | Dougbeh-Chris Nyan | Methods for real-time multiplex isothermal detection and identification of bacterial, viral, and protozoan nucleic acids |
| GB201519565D0 (en) | 2015-11-05 | 2015-12-23 | Alere San Diego Inc | Sample preparation device |
| EP3368654B1 (en) | 2015-10-30 | 2025-11-19 | Abbott Diagnostics Scarborough, Inc. | Determination of polymorphisms using isothermal nucleic acid amplification |
| US10329601B2 (en) | 2015-12-28 | 2019-06-25 | Ionian Technologies, Inc. | Nicking and extension amplification reaction (NEAR) of Streptococcus species |
| US9757728B2 (en) * | 2016-01-26 | 2017-09-12 | Lidong Qin | Microfluidic aliquoting for single-cell isolation |
| GB201602880D0 (en) | 2016-02-18 | 2016-04-06 | Ge Healthcare Uk Ltd | Method and composition for biomolecule stabilization |
| CN107119040A (zh) * | 2016-02-24 | 2017-09-01 | 青岛艾菲生物技术有限公司 | 一种等温核酸扩增的方法 |
| CA3016582A1 (en) | 2016-03-04 | 2017-09-08 | Alere San Diego, Inc. | Automated nested recombinase polymerase amplification |
| US9617587B1 (en) | 2016-04-04 | 2017-04-11 | Nat Diagnostics, Inc. | Isothermal amplification components and processes |
| US11299777B2 (en) * | 2016-04-04 | 2022-04-12 | Nat Diagnostics, Inc. | Isothermal amplification components and processes |
| US11268117B2 (en) | 2016-06-10 | 2022-03-08 | Life Technologies Corporation | Methods and compositions for nucleic acid amplification |
| WO2018140856A1 (en) | 2017-01-30 | 2018-08-02 | Bio-Rad Laboratories, Inc. | Emulsion compositions and methods of their use |
| WO2018140953A1 (en) | 2017-01-30 | 2018-08-02 | Abaxis, Inc. | Solution-based plasmon specific-binding partner assays and metallic nanostructures |
| CN106867998A (zh) | 2017-03-15 | 2017-06-20 | 郑州安图生物工程股份有限公司 | 高通量自动化从痰液样本中提取病原体核酸的试剂盒 |
| WO2019163064A1 (ja) | 2018-02-22 | 2019-08-29 | 学校法人 慶應義塾 | Ｐｃｒ成否判定法 |
| AU2020323881A1 (en) | 2019-07-26 | 2022-03-03 | Becton, Dickinson And Company | Buffer compositions for reducing aggregation |
| CN115605609A (zh) | 2020-04-08 | 2023-01-13 | 拜耳公司（De） | 使用rt-pcr的病毒感染的快速检测 |
| EP4308724A4 (en) | 2021-03-19 | 2025-05-14 | Becton, Dickinson and Company | ISOTHERMAL AMPLIFICATION OF PATHOGENS |
| US20250059612A1 (en) | 2022-02-05 | 2025-02-20 | Becton, Dickinson And Company | Method for separating genomic dna for amplification of short nucleic acid targets |
| WO2023150710A1 (en) | 2022-02-05 | 2023-08-10 | Becton, Dickinson And Company | Non-opaque lytic buffer composition formulations |
-
2016
- 2016-04-04 US US15/090,405 patent/US9617587B1/en active Active
-
2017
- 2017-03-06 AU AU2017247133A patent/AU2017247133B2/en active Active
- 2017-03-06 ES ES20182776T patent/ES2940071T3/es active Active
- 2017-03-06 WO PCT/US2017/020921 patent/WO2017176404A1/en not_active Ceased
- 2017-03-06 JP JP2019503197A patent/JP6758474B2/ja active Active
- 2017-03-06 EP EP20182776.3A patent/EP3760735B1/en active Active
- 2017-03-06 CA CA3018202A patent/CA3018202A1/en active Pending
- 2017-03-06 EP EP17711527.6A patent/EP3440217B1/en active Active
- 2017-03-06 ES ES22165594T patent/ES2988526T3/es active Active
- 2017-03-06 EP EP24156601.7A patent/EP4389910B1/en active Active
- 2017-03-06 ES ES17711527T patent/ES2881509T3/es active Active
- 2017-03-06 CN CN201780033123.7A patent/CN109196114A/zh active Pending
- 2017-03-06 EP EP22165594.7A patent/EP4053291B1/en active Active
-
2020
- 2020-05-27 JP JP2020092422A patent/JP7426901B2/ja active Active
-
2021
- 2021-08-13 US US17/402,358 patent/US11884969B2/en active Active
-
2022
- 2022-03-15 US US17/695,600 patent/US12351863B2/en active Active
- 2022-05-10 JP JP2022077421A patent/JP7571080B2/ja active Active
-
2023
- 2023-02-24 AU AU2023201140A patent/AU2023201140B2/en active Active
- 2023-12-14 US US18/540,659 patent/US20240209426A1/en active Pending
-
2024
- 2024-05-29 JP JP2024087154A patent/JP2024114703A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3440217B1 (en) | 2021-04-28 |
| US12351863B2 (en) | 2025-07-08 |
| EP3760735A1 (en) | 2021-01-06 |
| EP4389910A3 (en) | 2024-07-17 |
| JP2022111117A (ja) | 2022-07-29 |
| JP2020150948A (ja) | 2020-09-24 |
| JP2024114703A (ja) | 2024-08-23 |
| EP4389910B1 (en) | 2025-12-10 |
| US20220251629A1 (en) | 2022-08-11 |
| JP2019510515A (ja) | 2019-04-18 |
| CN109196114A (zh) | 2019-01-11 |
| WO2017176404A1 (en) | 2017-10-12 |
| AU2023201140B2 (en) | 2025-01-02 |
| US11884969B2 (en) | 2024-01-30 |
| EP4053291B1 (en) | 2024-05-01 |
| EP3440217A1 (en) | 2019-02-13 |
| ES2881509T3 (es) | 2021-11-29 |
| US20240209426A1 (en) | 2024-06-27 |
| ES2988526T3 (es) | 2024-11-20 |
| AU2023201140A1 (en) | 2023-03-30 |
| US9617587B1 (en) | 2017-04-11 |
| AU2017247133B2 (en) | 2023-02-09 |
| EP4389910A2 (en) | 2024-06-26 |
| JP7426901B2 (ja) | 2024-02-02 |
| EP3760735B1 (en) | 2022-12-14 |
| EP4053291A1 (en) | 2022-09-07 |
| JP7571080B2 (ja) | 2024-10-22 |
| AU2017247133A1 (en) | 2018-10-04 |
| CA3018202A1 (en) | 2017-10-12 |
| US20220064703A1 (en) | 2022-03-03 |
| JP6758474B2 (ja) | 2020-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2940071T3 (es) | Componentes y procedimientos de amplificación isotérmica | |
| US11118219B2 (en) | Isothermal amplification components and processes | |
| CN103620056B (zh) | 通过探测寡核苷酸切割及杂交的靶核酸序列的检测 | |
| CN106434857A (zh) | 靶区分性探针及其用途 | |
| US20090068643A1 (en) | Dual Function Primers for Amplifying DNA and Methods of Use | |
| KR20120084320A (ko) | Ｔｈｄ 프라이머 타겟 검출 | |
| WO2018031625A2 (en) | Rnase h mutants in an emulsion | |
| CN105705657A (zh) | 基于利用杂交-捕捉和模板化寡核苷酸的探测和标记寡核苷酸切割及延伸分析的在固相中的靶核酸序列检测 | |
| KR102678676B1 (ko) | 인공핵산을 이용한 표적핵산의 검출 방법 | |
| KR20250078890A (ko) | 주위 온도 핵산 증폭 및 검출 | |
| JP2025507309A (ja) | 核酸増幅のための内部対照 | |
| US20170044596A1 (en) | Methods and compositions for catalytic assays | |
| JP5299964B2 (ja) | Ｄｎａ３’末端の修飾基除去用酵素試薬 | |
| JP2025513875A (ja) | ポリヌクレオチド分析物を検出する方法 |